Neuroleptic treatment of negative symptoms in schizophrenic patients. Efficacy problems and methodological difficulties-Reference-Cited by-同舟云学术

Neuroleptic treatment of negative symptoms in schizophrenic patients. Efficacy problems and methodological difficulties

Published:1993-03 Issue:1 Volume:3 Page:1-11
ISSN:0924-977X
Container-title:European Neuropsychopharmacology
language:en
Short-container-title:European Neuropsychopharmacology

Author:

Möller H.-J.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,Clinical Neurology,Neurology,Pharmacology

Reference81 articles.

1. Factors determining patient tenure on a 3-year double-blind investigation of pimozide versus fluphenazine HCl;Abbuzzahab;Adv. Biochem. Psychopharmacol.,1980

2. A rating scale for emotional blunting;Abrams;Am. J. Psychiatry,1978

3. A controlled trial of pimozide and trifluoperazine and chronic schizophrenic syndromes;Andersen;Acta Pychiatr. Scand.,1974

4. Scale for the Assessment of Negative Symptoms (SANS);Andreasen,1981

5. Negative symptoms in schizophrenia: definition and reliability;Andreasen;Arch. Gen. Psychiatry,1982

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medications for Psychosis: Dopamine Blockers and Dopamine Partial Agonists (Antipsychotics);Tasman’s Psychiatry;2024

2. Medications for Psychosis: Dopamine Blockers and Dopamine Partial Agonists (Antipsychotics);Tasman’s Psychiatry;2023

3. Predictors of treatment outcome in depression in later life: A systematic review and meta-analysis;Journal of Affective Disorders;2018-02

4. Real-world Effectiveness of Antipsychotics for the Treatment of Negative Symptoms in Patients with Schizophrenia with Predominantly Negative Symptoms;Pharmacopsychiatry;2017-02-16

5. Antipsychotic Drugs;Psychiatry;2015-02-20